ECSP21019076A - Método de producción de derivados de 4-metoxipirrol - Google Patents

Método de producción de derivados de 4-metoxipirrol

Info

Publication number
ECSP21019076A
ECSP21019076A ECSENADI202119076A ECDI202119076A ECSP21019076A EC SP21019076 A ECSP21019076 A EC SP21019076A EC SENADI202119076 A ECSENADI202119076 A EC SENADI202119076A EC DI202119076 A ECDI202119076 A EC DI202119076A EC SP21019076 A ECSP21019076 A EC SP21019076A
Authority
EC
Ecuador
Prior art keywords
methoxypirrol
production method
derivatives production
derivatives
present disclosure
Prior art date
Application number
ECSENADI202119076A
Other languages
English (en)
Inventor
Jeong Hyun Son
Deok Ki Eom
Jeong Taek Shin
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of ECSP21019076A publication Critical patent/ECSP21019076A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente divulgación se refiere a un método de fabricación de derivados de 4-metoxipirrol. La realización de la presente divulgación es útil para la producción industrial en masa de derivados de 4-metoxipirrol, ya que se mejoran el rendimiento y la eficiencia del procedimiento y se evita el uso de reactivos peligrosos y reactivos contaminantes para el medioambiente.
ECSENADI202119076A 2018-09-19 2021-03-18 Método de producción de derivados de 4-metoxipirrol ECSP21019076A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
ECSP21019076A true ECSP21019076A (es) 2021-05-31

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202119076A ECSP21019076A (es) 2018-09-19 2021-03-18 Método de producción de derivados de 4-metoxipirrol

Country Status (20)

Country Link
US (1) US20210221770A1 (es)
EP (1) EP3854784A4 (es)
JP (1) JP7253624B2 (es)
KR (1) KR102126576B1 (es)
AU (1) AU2019343857B2 (es)
BR (1) BR112021005156A2 (es)
CA (1) CA3110830A1 (es)
CL (1) CL2021000639A1 (es)
CO (1) CO2021003195A2 (es)
DO (1) DOP2021000042A (es)
EC (1) ECSP21019076A (es)
JO (1) JOP20210040A1 (es)
MA (1) MA53673A (es)
MX (1) MX2021003137A (es)
NZ (1) NZ773997A (es)
PE (1) PE20211736A1 (es)
PH (1) PH12021550523A1 (es)
RU (1) RU2763287C1 (es)
SG (1) SG11202101919VA (es)
TN (1) TN2021000035A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
TW202241409A (zh) 2020-12-18 2022-11-01 南韓商大熊製藥股份有限公司 包含1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺醯基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺之用於經口投予的新調配物
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
WO2023229322A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법
WO2023229323A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173192B2 (ja) * 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
CA2647862A1 (en) 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Acid secretion inhibitor
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
BR112015010908A2 (pt) * 2012-11-19 2017-07-11 Jiangsu Hansoh Pharmaceutical Co Ltd derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo
JP2017071553A (ja) * 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine

Also Published As

Publication number Publication date
CO2021003195A2 (es) 2021-04-08
CL2021000639A1 (es) 2021-08-06
EP3854784A4 (en) 2022-03-30
KR102126576B1 (ko) 2020-06-24
TN2021000035A1 (en) 2022-10-03
NZ773997A (en) 2024-03-22
JP7253624B2 (ja) 2023-04-06
PE20211736A1 (es) 2021-09-06
JP2021535934A (ja) 2021-12-23
BR112021005156A2 (pt) 2021-06-15
CA3110830A1 (en) 2020-03-26
PH12021550523A1 (en) 2022-02-21
EP3854784A1 (en) 2021-07-28
MX2021003137A (es) 2021-05-14
MA53673A (fr) 2022-03-30
AU2019343857A1 (en) 2021-04-15
JOP20210040A1 (ar) 2021-03-07
AU2019343857B2 (en) 2021-12-02
US20210221770A1 (en) 2021-07-22
KR20200033178A (ko) 2020-03-27
RU2763287C1 (ru) 2021-12-28
DOP2021000042A (es) 2021-05-31
CN112739684A (zh) 2021-04-30
SG11202101919VA (en) 2021-04-29

Similar Documents

Publication Publication Date Title
ECSP21019076A (es) Método de producción de derivados de 4-metoxipirrol
CL2018001790A1 (es) Procesos para preparar un inhibidor de jak1 y nuevas formas de este (divisional solicitud 201602748)
EA201891657A1 (ru) Интегрированный процесс ферментации и электролиза
BR112019000718A2 (pt) processo para a produção de geopolímero ou compósito de geopolímero
PE20201263A1 (es) Suministro de cargas utiles a las celulas madre
AR101867A1 (es) Apuntalante curable a baja temperatura
UA117127C2 (uk) Спосіб одержання збагаченої вуглецем біомаси
BR112017000876A2 (pt) ?processo de fabricação de uma peça feita de material compósito de matriz de cerâmica, peça feita de material compósito de matriz de cerâmica, e, motor de turbina?
DOP2015000187A (es) Proceso de fabricación de vortioxetina
CL2020000869A1 (es) Enantiómeros de tiazoles sustituidos compuestos antivirales.
CO2017000367A2 (es) Producción microbiana de dioles grasos
UY36557A (es) Composición ácida a base de leonardita y aminoácidos
CL2019000016A1 (es) Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble.
BR112021022071A2 (pt) Substrato pulverulento obtido por craqueamento a vapor de uma biomassa sem agente auxiliar químico e suas utilizações
CL2021001511A1 (es) Novedosa psicosa-6-fosfato fosfatasa, composición para la producción de psicosa que comprende la misma y procedimiento para la producción de psicosa mediante el uso de la misma
AR113695A1 (es) Una d-psicosa 3-epimerasa y el uso de un método para producir d-psicosa
CR20170555A (es) Método para crear un compuesto a base de mercurio, compuesto a base de mercurio, métodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
GT201500225A (es) Proceso para producir compuesto de piridazinona y producciond e sus intermediarios
CO2021012174A2 (es) Microorganismo perteneciente al género staphylococcus que produce alulosa y procedimiento para la preparación de alulosa mediante el uso del mismo
CL2021000252A1 (es) Acelerador para composiciones aglutinantes minerales
CO2018013033A2 (es) Grasa vacuna en polvo
PE20142111A1 (es) Desactivacion microbial de composiciones explosivas
UY37059A (es) Contenedores de vidrio de alta resistencia
UY37060A (es) Contenedores de vidrio de alta resistencia